Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

1 Small-Cap Biotech That Analysts Expect to Triple

As psychedelic treatments gain traction, analysts predict triple-digit upside for this small-cap biotech stock.

Barchart

Chevron doctrine ruling a ‘gut-punch’ for US health and environment – experts

Decision that overturned convention of deference to federal agencies could upend regulations on tobacco, drugs and medical bills

The Guardian - US

Cannabis medications could be eligible for FDA approval under proposed DEA rules

For the first time, cannabis plant would drastically shift federal legal status from narcotic to regulated medication

The Guardian - US

From analysis to the latest developments in health,
read the most diverse news in one place.

FDA Bans Brominated Vegetable Oil In Food Products For Safety Concerns

Learn about the FDA's ban on BVO in food products and the health risks associated with this additive. Stay informed and make healthier choices for your diet.

Top News

Hot Ultrasound Waves Visibly Tightened My Loose Arm Skin

Sofwave, a non-invasive high-frequency device, toned my arms when weight lifting couldn't.

Marie Claire

Is there such a thing as too much coffee? Experts weigh in

An average adult is able to consume four to five cups of coffee per day

The Independent UK

Civil servants obliged to carry out Tory Rwanda deportations, court rules

Union for civil servants claimed Home Office staff could be open to prosecution if Strasbourg rulings on Rwanda ignored

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

3 Healthcare Stocks Set to Benefit From Aging Population Trends

The healthcare industry is set to grow significantly due to technological advances, an aging population, and increasing demand for quality healthcare. To that end, it could be wise to buy fundamentally strong healthcare stocks like Abbott Laboratories (ABT), Stryker (SYK), and Centene (CNC), which are set to benefit from these…

StockNews.com

FDA Bans Food Additive Found In Sports Drinks, Sodas Citing Safety Concerns

FDA revoked the authorization for the use of brominated vegetable oil, a common food additive used in sports drinks and sodas, citing safety concerns.

Medical Daily

What is brominated vegetable oil, and why did the FDA ban it in food?

The FDA will no longer allow BVO in food due to safety concerns revealed in studies.

LiveScience

SCOTUS Will Decide Whether the FDA's 'Regulatory Switcheroos' on Vaping Were 'Arbitrary and Capricious'

The 5th Circuit ruled that the agency violated the Administrative Procedure Act when it rejected applications from manufacturers of flavored nicotine e-liquids.

Reason

Cannabis will likely soon be legally classified as medicine. But medicine for what?

Experts say the DEA’s rescheduling of cannabis as a medication will be ‘a little bit incoherent’

The Guardian - US

What is the US Supreme Court and how does it work? Joe Biden says Trump immunity is 'dangerous' for America

The justices find that a president has immunity for ‘official acts’ but is not immune for ‘unofficial acts’ — and refer the matter back to a trial judge

Evening Standard

What Is Kisunla? Know All About New FDA-Approved Drug For Alzheimer's Disease

Kisunla manufactured by Eli Lilly could significantly slow cognitive decline in people with early symptomatic Alzheimer's disease, according to results of the company's clinical trials.

Medical Daily

Get all your
news in one place.

100's of premium titles.
One news app.

Top News

FDA Approves New Alzheimer's Drug To Slow Disease Progression

FDA approves Eli Lilly's donanemab for early Alzheimer's, offering hope for patients and caregivers. Treatment priced at 5 per vial.

The Independent UK

Health officials reveal cause of cucumber-related illnesses across America

Salmonella can cause symptoms that begin six hours to six days after ingesting the bacteria

The Independent UK

Diamond Shruumz microdosing candies may be linked to a death and nearly 50 illnesses

At least 48 people in 24 states said they got sick after eating Diamond Shruumz-brand products

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US

FDA approves second Alzheimer’s drug that can slow onset of disease

Eli Lilly says Kisunla demonstrated ‘meaningful results’ for people showing early symptoms of the disease

The Independent UK

FDA approves a second Alzheimer's drug that can modestly slow disease

U.S. health officials have approved a new Alzheimer’s drug that can modestly slow the disease

StockNews.com

3 Mid-Cap Stocks Analysts Believe Will Soar 50% or More

The blend of growth potential and stability in mid-cap pharma stocks is driven by rising demand for innovative therapies, strong economic conditions, and technological advancements that boost the sector's growth trajectory. Therefore, considering strong mid-cap stocks like Amphastar Pharmaceuticals (AMPH), Catalyst Pharmaceuticals (CPRX), and ACADIA Pharmaceuticals (ACAD), expected to soar…

Roll Call

Fight over flavored vapes lands at Supreme Court - Roll Call

The decision comes weeks after the FDA authorized the marketing of the first menthol-flavored vaping products.

Roll Call

Supreme Court to decide cases over online porn access, vapes - Roll Call

The Supreme Court announced Tuesday it will decide disputes over online access to pornography in Texas and FDA approval of vapes.

StockNews.com

Is Organogenesis a Hidden Gem in the Biotech Sector?

Given Organogenesis’s (ORGO) upbeat first-quarter results and promising development of its ReNu program for knee osteoarthritis, the company seems to be on the brink of significant growth. Let’s delve into its fundamentals to determine whether it's a hidden gem in the biotech sector. Read more to find out….

Latin Times

SCOTUS abortion 2024: while the issue may have had a good run, it may also set the stage for more restrictions

Two years after overturning Roe v. Wade, the Supreme Court takes on abortion once again. But its decisions may bring more restrictions in the long run

1 … 92 93 94 95

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.